Try our beta test site
Trial record 1 of 1 for:    VRC 601
Previous Study | Return to List | Next Study

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

This study has been completed.
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) ) Identifier:
First received: September 21, 2013
Last updated: January 24, 2017
Last verified: August 20, 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 20, 2015
  Primary Completion Date: August 20, 2015 (Final data collection date for primary outcome measure)